CTOR vs ICE · $105.2M cap vs P/E 37, rev $12.64B
Citius Oncology, Inc. (CTOR) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
CTOR does not have a complete income-statement cache yet.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
CTOR currently screens at market cap $105.2M. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the CTOR and ICE stock pages for the full models.
Not investment advice.